Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc.

World Rank (Jan-05-2024)
6,533
Market Cap (Jan-05-2024)
1.596 Billion USD
World Rank (Jul-30-2023)
4,497
Market Cap (Jul-30-2023)
2.874 Billion USD
World Rank (Jan-07-2022)
3,616
Market Cap (Jan-07-2022)
4.397 Billion USD
World Rank (Jan-01-2021)
2,184
Market Cap (Jan-01-2021)
7.226 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
MRVI
Market Cap (Mar-08-2026)
0.91
Employee Count
490
Employee Count as of Date
As on June 2021
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
883 Million USD
Annual Operating Income in USD
566 Million USD
Annual Net Income in USD
220 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
2,282 Million USD
Total Liabilities in USD
1,377 Million USD
Total Equity in USD
905 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Biotechnology
Company Website
MARAVAI LIFESCIENCES HOLDINGS, INC.
Yahoo
Yahoo @ Nasdaq
Company Profile

Maravai LifeSciences Holdings is a biotechnology sector company related to providing products and services into the fields of nucleic acid production, biologics safety testing and protein detection to many of the worlds leading biopharma, vaccine, diagnostics, and cell and gene therapy companies. It has 390 employees as on 2019. The headquarters is in USA.

Annual Results Summary

MARAVAI LIFESCIENCES HOLDINGS, INC. - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022883566220
Dec-2021799543 182
Dec-202028410076
Dec-201914324-4 (Loss)
Dec-201812317-17 (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 2,282 Million USD.

Total Liabilities as on Dec-2022 was 1,377 Million USD.

Total Equity as on Dec-2022 was 905 Million USD

Founded Year
2020
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share